Authors
Latest:
Melissa L. Bondy on the Importance of Finding Glioma-Causing GenesMelissa L. Bondy, PhD, MS, associate director for cancer prevention and population sciences at Baylor College of Medicine, discusses the importance of finding genetic mutations that can cause cancers such as glioma.
Latest:
Bioimpedance Spectroscopy Can Help Prevent Clinical LymphedemaSeveral breast cancer treatment programs are reporting substantially less clinical lymphedema, particularly among patients at high risk after axillary dissection, radiation, or taxane-based chemotherapy, crediting their use of preclinical detection using bioimpedance spectroscopy (BIS).
Latest:
Rebecca Lehto Discusses Holistic TreatmentRebecca Lehto, PhD, RN, OCN, assistant professor, College of Nursing, Michigan State University, discusses holistically treating patients with cancer.
Latest:
Is It OK for an Oncology Nurse to Attend a Patient's Funeral?Consider the family's feelings and check workplace policies when determining how best to share condolences and cope with your grief.
Latest:
Michelle Gervino Discusses Side Effect Management in Patients with Hematologic MalignanciesMichelle Gervino, RN, BSN, OCN, John Theurer Cancer Center, discusses side effects that patients with hematologic malignancies may experience during treatment
Latest:
Sharon L. Bober, PhD, Discusses Sexual Health Changes in Relation to TreatmentSharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses how changes in sexual health differ with various treatments.
Latest:
More for Melanoma: Nurse Discusses Unmet NeedsDespite many exciting advances in recent years, there are still aspects of melanoma treatment that need to be further studied and understood, said Grace Cherry, NP, a nurse practitioner at UCLA Health.
Latest:
Deborah Watkins Bruner Discusses Financial ToxicityDeborah Watkins Bruner advises nurses on how they can help patients with cancer who are struggling financially.
Latest:
Rosanne Casal on Sending Patients With Cancer Through the Emergency RoomRosanne Casal, MSN, APN-BC, AOCNP, of University Hospitals Seidman Cancer Center discusses why patients with cancer should not be sent through the emergency room.
Latest:
Zero Tolerance: Stopping Nurse Bullying Begins With LeadershipNo longer simply accepted as part of the culture of nursing, bullying must be acknowledged and addressed. It starts with education and a commitment to a healthy work environment.
Latest:
Jame Abraham on Managing Time for Patients Undergoing Scalp CoolingJame Abraham highlights the importance of time management for patients undergoing scalp cooling.
Latest:
Colleen O'Leary Discusses How Nurses Guide TreatmentColleen O’Leary, associate director for nursing education, The Ohio State University James Cancer Hospital, discusses the vital role nurses play in guiding the treatment of their patients with cancer.
Latest:
Nicole Makris Discusses HPV Vaccination in Women who have Sex with WomenNicole Makris, BA, Emory University, discusses the findings that analyzed the HPV vaccination habits of women who have sex with women versus women who have sex with men.
Latest:
Dr. Wong on Easing the Symptoms of ChemobrainSerena Wong, MD, medical oncologist, Stacy Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses ways to ease the symptoms of chemobrain.
Latest:
Eileen Eisenhower on the Benefits of Keeping Emergency Supplies in the Infusion RoomEileen Eisenhower, RN, BSN, CRNI, OCN, discusses the improvements to the CTCA-Eastern infusion room since they've added an emergency supplies box to handle hypersensitivity reactions.
Latest:
Optimal Strategies Expand How Oncologists Target Treatment in NSCLCThe acceptance of next-generation sequencing (NGS) platforms and cell-free DNA (cfDNA) have enabled oncologists to more specifically target genetic mutations in the treatment of patients with non–small cell lung cancer (NSCLC), according to Benjamin P. Levy, MD.
Latest:
Modifying Talquetamab Doses for Myeloma Continues Efficacy, Reduces Side EffectsReducing the dose of talquetamab, a GPRC5D/CD3 bispecific antibody, may improve side effect rates while maintain high response rates in patients with relapsed or refractory multiple myeloma.
Latest:
One Nurse's Perspective on the Reality Behind Having CancerPatients who are diagnosed with cancer have cancer, cancer does not have them; they reflect what it means to be strong, a perfect picture of tenacity.
Latest:
Helping Your Patients Understand and Prevent Gynecologic CancersGynecologic cancers present some of the most dangerous cancer-related threats to women, here's how to help patients understand what to look out for and the realities of their treatment.
Latest:
Norman (Carl) Swart on Palliative Care and Challenges Nurses FaceNorman (Carl) Swart, PhD nursing student, Case Western Reserve University, defines palliative care and discusses challenges that nurses face.
Latest:
CDK4/6 Inhibitors Are Tested in Adjuvant SettingAlthough ET significantly reduces the risk of HRpositive/ HER2- negative early breast cancer, the cumulative risk of distant recurrence has remained steady for decades.
Latest:
Kevin Hughes on Dense Breast Tissue and Cancer RiskKevin Hughes, MD, breast surgeon at Massachusetts General Hospital, discusses misconceptions regarding dense breast tissue and risk for breast cancer.
Latest:
Kathi Mooney on Using an Automated Remote Monitoring System for Patients After Chemotherapy TreatmentKathi Mooney, PhD, RN, FAAN, Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing, College Of Nursing, University of Utah, Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute, discusses using an automated remote monitoring system to improve patients' side effects following chemotherapy treatment.
Latest:
Immune-Related Adverse Events: What to KnowManaging immune-related adverse events is different from managing the effects of chemotherapy.
Latest:
Leslie Schover on Psychological Elements of Sexual DysfunctionLeslie Schover, PhD, clinical psychologist and professor of Behavioral Science at the University of Texas MD Anderson Cancer Center, discusses the psychological elements of sexual dysfunction after cancer.
Latest:
Blake A. Morrison on Infusion Reactions With New Agents for Multiple MyelomaBlake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Latest:
Julia Whiteker Describes the ONS Breast Care SIGJulia Whiteker Describes the ONS Breast Care SIG Online Community
